838 results on '"Nestel, Paul"'
Search Results
152. Apoprotein C Metabolism in Man
153. Chapter 5 The regulation of lipoprotein metabolism
154. Hyperlipoproteinaemia and Vascular Disease
155. List of Contributors
156. Cholesterol Turnover in Man
157. Reply
158. Association of Contemporary Sensitive Troponin I Levels at Baseline and Change at 1 Year With Long-Term Coronary Events Following Myocardial Infarction or Unstable Angina
159. The role of reducing intakes of saturated fat in the prevention of cardiovascular disease:where does the evidence stand in 2010?
160. Modifications in dietary fat quality are associated with changes in serum lipids of older adults independently of lipid medication
161. Sympathetic neural adaptation to hypocaloric diet with or without exercise training in obese metabolic syndrome subjects
162. The effects of dietary weight loss on indices of norepinephrine turnover: Modulatory influence of hyperinsulinemia
163. Plasma Lipoprotein(a) Concentration Predicts Future Coronary and Cardiovascular Events in Patients With Stable Coronary Heart Disease
164. Effects of low-fat or full-fat fermented and non-fermented dairy foods on selected cardiovascular biomarkers in overweight adults
165. Perspective
166. 393 NEUROADRENERGIC DYSFUNCTION ALONG THE DIABETIC CONTINUUM
167. Mechanism of systemic cholesterol efflux in humans after infusion of reconstituted high density lipoprotein
168. Nutrition and metabolism
169. Mechanism of cholesterol efflux in humans after infusion of reconstituted high-density lipoprotein
170. Exercise augments weight loss induced improvement in renal function in obese metabolic syndrome individuals
171. The Effects of Weight LossVersusWeight Loss Maintenance on Sympathetic Nervous System Activity and Metabolic Syndrome Components
172. Sympathetic Neural Adaptation to Hypocaloric Diet With or Without Exercise Training in Obese Metabolic Syndrome Subjects
173. Weight Loss May Reverse Blunted Sympathetic Neural Responsiveness to Glucose Ingestion in Obese Subjects With Metabolic Syndrome
174. Trans fatty acids and cardiovascular risk markers: does the source matter?
175. Blunted sympathetic neural response to oral glucose in obese subjects with the insulin-resistant metabolic syndrome
176. Effect of dietary cholesterol in normolipidemic subjects is not modified by nature and amount of dietary fat
177. Cardiovascular disease risk factors in free-living men: comparison of two prudent diets, one based on lactoovovegetarianism and the other allowing lean meat
178. Post-prandial remnant lipids impair arterial compliance
179. Effects of Dairy Fats within Different Foods on Plasma Lipids
180. Indices of reverse cholesterol transport in subjects with metabolic syndrome after treatment with rosuvastatin
181. Dose-dependent effect of rosuvastatin on apolipoprotein B-100 kinetics in the metabolic syndrome
182. Antiatherogenic Functionality of High Density Lipoprotein: How Much versus How Gooden-subtitle=
183. Conference report: Dietary guidelines for a new millennium
184. A 1,3-diacylglycerol-rich oil induces less atherosclerosis and lowers plasma cholesterol in diabetic apoE-deficient mice
185. An isoflavone metabolite reduces arterial stiffness and blood pressure in overweight men and postmenopausal women
186. Indications for Omega-3 Long Chain Polyunsaturated Fatty Acid in the Prevention and Treatment of Cardiovascular Disease.
187. The cis-9,trans-11 isomer of conjugated linoleic acid (CLA) lowers plasma triglyceride and raises HDL cholesterol concentrations but does not suppress aortic atherosclerosis in diabetic apoE-deficient mice
188. Neither plasma coenzyme Q10 concentration, nor its decline during pravastatin therapy, is linked to recurrent cardiovascular disease events: A prospective case–control study from the LIPID study
189. Elevated HDL Cholesterol is Functionally Ineffective in Cardiac Transplant Recipients: Evidence for Impaired Reverse Cholesterol Transport
190. Relation of diet to cardiovascular disease risk factors in subjects with cardiovascular disease in Australia and New Zealand: analysis of the Long-Term Intervention with Pravastatin in Ischaemic Disease trial
191. White Blood Cell Count Predicts Reduction in Coronary Heart Disease Mortality With Pravastatin
192. Physical Fitness and Reverse Cholesterol Transport
193. Isoflavones: effects on cardiovascular risk and functions
194. The Isoflavone Metabolite Cis-Tetrahydrodaidzein Inhibits ERK-1 Activation and Proliferation in Human Vascular Smooth Muscle Cells
195. Isoflavones Reduce Arterial Stiffness
196. Single session exercise stimulates formation of preβ1-HDL in leg muscle
197. Comparison of fat intake in Australian and New Zealand CHD patients: The lipid (long-term intervention with pravastatin in ischaemic disease) study
198. Role of Soy Protein in Cholesterol-Lowering
199. Delineation of the Role of Pre-β 1 -HDL in Cholesterol Efflux Using Isolated Pre-β 1 -HDL
200. Adulthood — treatment
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.